Discover the critical insights from a rare case of duodenal perforation during advanced gastric cancer treatment with Ramucirumab and Nab-Paclitaxel, highlighting the delicate balance in palliative care.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
[A Case of Perforation of the Duodenum during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Advanced Gastric Cancer].
Hanayama et al., Gan To Kagaku Ryoho 2023
PMID: 38303366
Listen, we had this 70-year-old guy, a real fighter, diagnosed with some serious, very advanced gastric cancer. This isn’t just any cancer, we’re talking big league – it spread to the lymph nodes near the aorta. The best doctors did a laparoscopy, and then they hit him with not one, but two rounds of the toughest chemo before surgery.
Then, they went in and did a huge operation – took out part of his stomach, cleared the lymph nodes, and rebuilt his digestive tract. They found this huge lymph node during surgery, and the pathology came back – it was a tough stage, Stage IVB, very tough.
But our guy, he’s a fighter, remember? Six weeks later, he’s back at it with more chemo, this time with ramucirumab and nab-paclitaxel. But then, there’s a setback – an abscess from a duodenal perforation. They drained it like pros, no big deal.
They switch up his treatment, adding nivolumab and some other big drugs. But the cancer’s a tough opponent, it spreads to his brain. So, they move to comfort care – the best care – and he battles for two years and seven months. A real fighter, but in the end, the disease was just too much.